-
News | 2023.12.18
Climate and health: the latest on a silent epidemic
While the main outcome of COP28 was an agreement calling on the parties to "transition away from fossil fuels" with the aim of limiting climate change, it was also the first COP to include a Health Day. Rising global temperatures, extreme meteorological phenomena and ecosystem change are not merely environmental concerns. They are catalysts of a silent epidemic that is affecting human health....
-
News | 2023.09.05
HIV-AIDS: broadly neutralizing antibodies, stars of the lab
Highly promising, broadly neutralizing antibodies can react with the vast majority of HIV particles to cause their destruction by the body. However, the latter would have to be able to produce equally effective antibodies...
-
Document de presse | 2024.05.17
The Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Ceará
Inaugurated this Friday (5/17), the Pasteur Fiocruz Center on Immunology and Immunotherapy, located in Fiocruz-Ceará, brings together scientists from the Institut Pasteur and Fiocruz, two Pasteur Network members, to develop an integrative approach to immunotherapies applied to both infectious and non-communicable diseases. This scientific cooperation aims to accelerate research in immunology and...
-
Fiche maladie | 2016.06.24
Poliomyelitis
Poliomyelitis is a highly contagious disease caused by a virus (the poliovirus), which invades the nervous system and can lead to irreversible paralysis in just a few hours. It mostly affects children under the age of five. The disease has been preventable since the 1960s thanks to effective vaccines. A global program, aiming to eradicate the disease through vaccination, was launched under the...
-
Fiche maladie | 2017.04.24
Antibiotic resistance
Antibiotics are drugs used to treat infections caused by bacteria. Antibiotic resistance occurs when bacteria become resistant and no longer respond to these drugs.
-
Document de presse | 2024.11.21
Phages, towards a targeted alternative to antibiotics
With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat bacterial infections, phage therapy is once again sparking interest among physicians and scientists – although it remains complex in...
-
Article | 2019.06.18
Bacteria
34 teams from seven departments are addressing the antibiotic resistance challenge with multidisciplinary approaches to characterize and prevent the emergence and the dissemination of antibiotic resistance genes and resistant bacteria and to develop new drugs and alternative strategies to fight bacterial infections.
-
Article | 2023.04.04
4-year Research Group - Call for nomination at the Pasteur Fiocruz Center
A 4-year Group leaders’ position is open at the Pasteur Fiocruz Center on Immunology and Immunotherapy
-
Document de presse | 2015.10.28
The Institut Pasteur and Chan Soon-Shiong Institute for Molecular Medicine Partner to Form Global Genomics Center
Paris, France and Los Angeles, CaliforniaThe Chan Soon-Shiong Institute for Molecular Medicine (CSSIOMM) and the Institut Pasteur today announced a partnership to establish The Pasteur Global Health Genomics Center (PGHGC). The aim of the PGHGC is to advance genomic research utilizing next-generation patient information systems needed to support the acquisition and usage of high-quality...
-
News | 2023.03.22
The origins of SARS-CoV-2: the search goes on
Where did SARS-CoV-2 come from? How did this virus enter the human population? These questions still remain unanswered. In June 2022, a group of experts, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) commissioned by the World Health Organization (WHO), published a report on the origin of coronavirus but was unable to draw a definitive conclusion. Since then, research has...